Erythrocyte contribution to coagulopathy and cerebral oxygenation after intracerebral hemorrhage
红细胞对脑出血后凝血障碍和脑氧合的贡献
基本信息
- 批准号:10681478
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:Activated Partial Thromboplastin Time measurementAcuteAdmission activityAffectAnemiaAnimal ExperimentationAnimalsAntifibrinolytic AgentsBackBindingBlood Coagulation DisordersBlood Coagulation FactorBlood PlateletsBlood TestsBlood coagulationCerebral HypoxiaCerebral hemisphere hemorrhageCerebrumCessation of lifeClinicalClinical TrialsCoagulation ProcessDataEndotheliumErythrocyte TransfusionErythrocytesEventFibrinogenFutureHematomaHemorrhageHemostatic functionHourHumanImpairmentInjuryKnowledgeLiteratureMeasuresMediatingMethodological StudiesMonitorMorbidity - disease rateObservational StudyOutcomeOxygenPatient-Focused OutcomesPatientsPlasmaPlatelet Count measurementPlatelet TransfusionProthrombin time assayRadialResearchRiskRisk FactorsRoleScalp structureStrokeSubarachnoid HemorrhageTBI PatientsTestingThrombelastographyTissuesTrainingTransfusionTraumatic Brain InjuryVenousWhole Bloodbench to bedsidecerebral oxygenationclinically relevantdisabilityhuman studyimprovedimproved outcomeinnovationinsightinterstitialmortalitymouse modelnovelpatient populationpreventprospectiveskillsstroke patienttissue oxygenationtooltranslational scientist
项目摘要
PROJECT SUMMARY:
Intracerebral hemorrhage (ICH) carries the highest morbidity and mortality of all stroke subtypes due to the
initial injury and the ongoing bleeding, otherwise known as hematoma expansion (HE), which can occur
afterwards. HE occurs acutely within 24 hours in up to 30% of patients with ICH and is the strongest driver of
worse outcomes in this patient population. Consequently, acute ICH treatment paradigms largely focus on
preventing HE utilizing rapid transfusion based approaches in efforts to improve outcome. However, recent
trials using generalized, rapid transfusion based treatment approaches with coagulation factors or platelet
transfusions to prevent HE have not yielded improved outcomes. This emphasizes a critical knowledge gap in
approaches and treatment targets of HE.
Lower red blood cell (RBC) levels have been associated with bleeding with proposed mechanisms being due
to suboptimal radial displacement of platelets and endothelial binding. While evidence in ICH has consistently
revealed an association of low RBC levels with worse outcomes, this has largely been attributed to impaired
cerebral oxygenation rather than coagulopathy. This extrapolates the associations of low RBC levels with
impaired cerebral oxygenation and poor clinical outcomes from subarachnoid hemorrhage and traumatic brain
injury patient populations as no such studies have yet been performed in ICH. However, there is evidence of
larger baseline hematoma volumes and more recently, increased HE in ICH patients with lower baseline RBC
levels to suggest a role of coagulopathy related to RBC levels in these patients.
The role of RBCs on functional coagulation and cerebral oxygenation after ICH will be investigated via a)
reductionist murine models of anemia, ICH and RBC transfusions and b) a prospective observational human
ICH study evaluating the relationship of RBC levels and RBC transfusions on independent changes in
functional coagulation and cerebral oxygenation. This project will fill an important gap in ICH treatment
paradigms by establishing novel tools to investigate mechanisms of RBC levels on ICH outcomes in order to
ultimately inform future clinical transfusion based treatment approaches in patients with ICH to improve their
outcomes.
项目概要:
脑出血(ICH)是所有卒中亚型中发病率和死亡率最高的,
初始损伤和持续出血,也称为血肿扩大(HE),可能发生
事后在高达30%的ICH患者中,HE在24小时内急性发生,并且是ICH的最强驱动因素。
这一患者人群的预后更差。因此,急性ICH治疗模式主要集中在
利用基于快速输血的方法预防HE,努力改善结局。但最近的
使用广泛的、基于快速输血的凝血因子或血小板治疗方法的试验
输血预防肝性脑病并没有产生改善的结果。这突出表明,
肝性脑病的治疗途径和治疗目标。
较低的红细胞(RBC)水平与出血有关,
血小板和内皮结合的次优径向位移。虽然ICH中的证据一直
揭示了低RBC水平与更差结果的相关性,这在很大程度上归因于受损
脑氧合而不是凝血功能障碍。这推断了低RBC水平与
蛛网膜下腔出血和脑外伤导致的脑氧合受损和临床结局不良
由于尚未在ICH中进行此类研究,因此,然而,有证据表明,
在基线RBC较低的ICH患者中,基线血肿体积较大,最近HE增加
水平,以表明这些患者中与RBC水平相关的凝血病的作用。
将通过以下方式研究RBC在ICH后功能性凝血和脑氧合中的作用:a)
贫血、ICH和RBC输注的还原论小鼠模型和B)前瞻性观察人类
ICH研究,评价RBC水平和RBC输注对独立变化的关系,
功能性凝血和脑氧合。该项目将填补ICH治疗的一个重要空白
通过建立新的工具来研究RBC水平对ICH结局的机制,
最终为ICH患者未来基于输血的临床治疗方法提供信息,
结果。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Red Blood Cell Transfusions Are Not Associated With Incident Complications or Poor Outcomes in Patients With Intracerebral Hemorrhage.
- DOI:10.1161/jaha.122.028816
- 发表时间:2023-06-06
- 期刊:
- 影响因子:5.4
- 作者:Poyraz, Fernanda Carvalho;Boehme, Amelia;Cottarelli, Azzurra;Eisler, Lisa;Elkind, Mitchell S. V.;Ghoshal, Shivani;Agarwal, Sachin;Park, Soojin;Claassen, Jan;Connolly, E. Sander;Hod, Eldad A.;Roh, David J.
- 通讯作者:Roh, David J.
Admission viscoelastic hemostatic assay parameters predict poor long-term intracerebral hemorrhage outcomes.
入院粘弹性止血测定参数可预测长期脑出血预后不良。
- DOI:10.21203/rs.3.rs-4087284/v1
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Sieh,Laura;Peasley,Emma;Mao,Eric;Mitchell,Amanda;Heinonen,Gregory;Ghoshal,Shivani;Agarwal,Sachin;Park,Soojin;Connolly,ESanderSander;Claassen,Jan;Moore,ErnestE;Hansen,Kirk;Hod,EldadA;Francis,RichardO;Roh,David
- 通讯作者:Roh,David
Hemoglobin Concentration Impacts Viscoelastic Hemostatic Assays in ICU Admitted Patients.
血红蛋白浓度影响 ICU 入院患者的粘弹性止血测定。
- DOI:10.1097/ccm.0000000000005700
- 发表时间:2023
- 期刊:
- 影响因子:8.8
- 作者:Roh,DavidJ;Chang,TiffanyR;Kumar,Aditya;Burke,Devin;Torres,Glenda;Xu,Katherine;Yang,Winni;Cottarelli,Azzurra;Moore,Ernest;Sauaia,Angela;Hansen,Kirk;Velazquez,Angela;Boehme,Amelia;Vrosgou,Athina;Ghoshal,Shivani;Park,Soojin;
- 通讯作者:
The author replies.
作者回复。
- DOI:10.1097/pcc.0000000000000062
- 发表时间:2014
- 期刊:
- 影响因子:0
- 作者:Vavilala,MonicaS
- 通讯作者:Vavilala,MonicaS
ABO Blood Type and Thromboembolic Complications after Intracerebral Hemorrhage: an exploratory analysis.
ABO 血型和脑出血后血栓栓塞并发症:探索性分析。
- DOI:10.21203/rs.3.rs-3108135/v1
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Ironside,Natasha;Melmed,Kara;Chen,Ching-Jen;Omran,Setareh;Park,Soojin;Agarwal,Sachin;Connolly,ESander;Claassen,Jan;Hod,EldadA;Roh,David
- 通讯作者:Roh,David
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Roh其他文献
David Roh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Roh', 18)}}的其他基金
Erythrocyte contribution to coagulopathy and cerebral oxygenation after intracerebral hemorrhage
红细胞对脑出血后凝血障碍和脑氧合的贡献
- 批准号:
10472458 - 财政年份:2021
- 资助金额:
$ 19万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 19万 - 项目类别:
Standard Grant